Successful Statistical Strategies for Patient Screening and Stratification
About this webinar
The outcome of clinical trials is often determined by the quality of the data gathered; however, the strategy for statistical analysis can be crucial for success. By considering the value of data available throughout every stage of a cognitive study, the potential to detect an efficacy signal can be increased.
In this webinar, we explore how purposeful consideration of statistical analysis can drive efficiencies throughout your study, from pre-screening strategies to identify and recruit a homogenous target population, to stratification of patients to improve the signal-to-noise ratio.
You will learn:
- How to integrate statistical planning into a cognitive study design
- Pre-screening, patient stratification, and when they have the most benefit
- Deep dive into how a successful statistical strategy has supported a clinical study
Who should attend
- Data analysis
- Data management
- Data science
- Statistical analysis
- Clinical innovation
- Clinical operations
- Digital biomarkers
- Digital strategy
- Drug development
- Medical affairs
- Patient engagement
- Virtual trials
What you will learn
- How to integrate statistical planning into a cognitive study design
- Pre-screening, patient stratification, and when they have the most benefit
- Deep dive into how a successful statistical strategy has supported a clinical study
Featured Speakers
Elizabeth Baker, PhD
Working with pharmaceutical, biotechnology and academic clients, Elizabeth develops statistical analysis protocols for the analysis of cognitive endpoints in clinical trials and observational research studies. Since joining Cambridge Cognition in 2017, Elizabeth has supported the development of clinical trial enrichment tools, implemented Bayesian methodologies and conducted statistical analysis across a range of clinical trial designs and CNS disorders.
Elizabeth has a keen interest in the application of longitudinal analysis techniques and machine learning to clinical cohorts and is a fellow of the Royal Statistical Society. Elizabeth received her PhD in Biostatistics and Health Informatics from King’s College London.
Partner for this event
Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
Related webinars
More from Cambridge Cognition.
Real-World Measurement of Cognition and Mood in Frontline COVID-19 Healthcare Workers
Decentralised Trials in Psychiatry: From Feasibility to Novel Insights
Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape
Digital Health: Optimizing Clinical Trials with Patient-Centric Technology
Early Alzheimer’s Disease: Finding the Right Patients for Clinical Trials and Beyond
Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success
Leveraging Cognitive Measures in Clinical Trials